Literature DB >> 19923705

A conformational polymorphic transition in the high-temperature epsilon-form of chlorpropamide on cooling: a new epsilon'-form.

Tatiana N Drebushchak1, Yury A Chesalov, Elena V Boldyreva.   

Abstract

Structural changes in the high-temperature -polymorph of chlorpropamide, 4-chloro-N-(propylaminocarbonyl)benzenesulfonamide, C(10)H(13)ClN(2)O(3)S, on cooling down to 100 K and on reverse heating were followed by single-crystal X-ray diffraction. At temperatures below 200 K the phase transition into a new polymorph (termed the epsilon'-form) has been observed for the first time. The polymorphic transition preserves the space group Pna2(1), is reversible and is accompanied by discontinuous changes in the cell volume and parameters, resulting from changes in molecular conformation. As shown by IR spectroscopy and X-ray powder diffraction, the phase transition in a powder sample is inhomogeneous throughout the bulk, and the two phases co-exist in a wide temperature range. The cell parameters and the molecular conformation in the new polymorph are close to those in the previously known alpha-polymorph, but the packing of the z-shaped molecular ribbons linked by hydrogen bonds inherits that of the epsilon-form and is different from the packing in the alpha-polymorph. A structural study of the alpha-polymorph in the same temperature range has revealed no phase transitions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923705     DOI: 10.1107/S010876810903290X

Source DB:  PubMed          Journal:  Acta Crystallogr B        ISSN: 0108-7681


  2 in total

1.  Crystal structure of 4-bromo-N-(propyl-carbamo-yl)benzene-sulfonamide.

Authors:  Mustafa Bookwala; Saloni Patel; Patrick T Flaherty; Peter L D Wildfong
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2022-04-07

2.  Conformational aspects of polymorphs and phases of 2-propyl-1H-benzimidazole.

Authors:  Fco Javier Zuñiga; Aurora J Cruz-Cabeza; Xabier M Aretxabaleta; Noelia de la Pinta; Tomasz Breczewski; María Mar Quesada-Moreno; Juan Ramón Avilés-Moreno; Juan Jesús López-González; Rosa M Claramunt; Jose Elguero
Journal:  IUCrJ       Date:  2018-09-14       Impact factor: 4.769

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.